SCOTT SULLIVAN: Open Payments
NPI 1477592988 · EAST PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 34 payments from 13 companies in 2025. Trend: 2023 $715 · 2024 $737 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $271 |
| Novo Nordisk Inc | 5 | $104 |
| Phathom Pharmaceuticals, Inc. | 2 | $68 |
| ABBVIE INC. | 3 | $64 |
| Abbott Laboratories | 3 | $53 |
| Inspire Medical Systems, Inc. | 2 | $39 |
| InSightec,Inc | 1 | $32 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $30 |
| Amgen Inc. | 1 | $27 |
Products named: AIRSUPRA, FARXIGA, VOQUEZNA, FREESTYLE LIBRE 3, Wegovy, BREZTRI, LINZESS, INSPIRE.
Industry payments across RI — which companies pay providers there.
